Bupevecaine

PreclinicalSmall molecule

Bupevecaine is one of 17 small molecule programs targeting Laparoscopic Cholecystectomy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Laparoscopic CholecystectomyUnknown status

Laparoscopic CholecystectomyPreclinical

Unknown status

Competition

Competitive Landscape

22 competitors in Laparoscopic Cholecystectomy

#DrugCompanyPhaseTrials

Marcaine

IInnocoll

Approved

14 2

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

11 3

Duragesic

CCephalon

Approved

6 4

Kytril

CConrado Roberto Hoffmann Filho

Approved

2 5

Nubain

AAultman Health Foundation

Approved

2 6

Bupivacaine and Fentanyl

WWeill Medical College of Cornell University

Phase 3

1 7

Bupivacaine and Dexmedetomidine

KKafrelsheikh University

Phase 3

1 8

Magnesium Sulfate 24 Hours

IInstituto Materno Infantil Prof. Fernando Figueira

Phase 3

1 9

Epsom Salt

FFresenius Kabi USA, LLC

Preclinical

6 10

Spravato

WWim Janssens

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Laparoscopic Cholecystectomy1 trial

Magnesium Sulfate for TAP Analgesia During Laparoscopic Cholecystectomy

Unknown status·MMansoura University·N/A·NCT02533284·90 enrolled

Hepatectomy1 trial

Transversus Abdominus Plane Block in Living Donor Hepatectomy

Completed·AAlRefaey Kandeel·N/A·NCT02708459·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Bupevecaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bupevecaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bupevecaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMansoura University

Bupevecaine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Laparoscopic Cholecystectomy1 trial

Hepatectomy1 trial

References

Drug Info

Quick Facts

Related News